Singh et al., 2013 - Google Patents
Microglial nodules in early multiple sclerosis white matter are associated with degenerating axonsSingh et al., 2013
View HTML- Document ID
- 16953766929005364601
- Author
- Singh S
- Metz I
- Amor S
- van der Valk P
- Stadelmann C
- Brück W
- Publication year
- Publication venue
- Acta neuropathologica
External Links
Snippet
Microglial nodules in the normal-appearing white matter have been suggested as the earliest stage (s) of multiple sclerosis (MS) lesion formation. Such nodules are characterized by an absence of leukocyte infiltration, astrogliosis or demyelination, and may develop into …
- 201000006417 multiple sclerosis 0 title abstract description 133
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2828—Prion diseases
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Singh et al. | Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons | |
Heß et al. | Lesion stage-dependent causes for impaired remyelination in MS | |
Dziedzic et al. | Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis | |
Lassmann | The architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis | |
Rockenstein et al. | Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo | |
Ngolab et al. | Brain-derived exosomes from dementia with Lewy bodies propagate α-synuclein pathology | |
Rodriguez-Rodriguez et al. | Tau hyperphosphorylation induces oligomeric insulin accumulation and insulin resistance in neurons | |
Rey et al. | Widespread transneuronal propagation of α-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson’s disease | |
Behrendt et al. | Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men | |
Rasmussen et al. | Persistent activation of microglia is associated with neuronal dysfunction of callosal projecting pathways and multiple sclerosis-like lesions in relapsing–remitting experimental autoimmune encephalomyelitis | |
Wang et al. | Somatodendritic accumulation of misfolded SOD1-L126Z in motor neurons mediates degeneration: αB-crystallin modulates aggregation | |
Robinson et al. | TDP-43 skeins show properties of amyloid in a subset of ALS cases | |
Hametner et al. | Iron and neurodegeneration in the multiple sclerosis brain | |
Buss et al. | Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord | |
Jolanda Münzel et al. | Promoting remyelination in multiple sclerosis—recent advances | |
Herber et al. | Biochemical and histochemical evidence of nonspecific binding of α7nAChR antibodies to mouse brain tissue | |
Rey et al. | Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein | |
Yang et al. | Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain | |
Lüders et al. | Maintenance of high proteolipid protein level in adult central nervous system myelin is required to preserve the integrity of myelin and axons | |
Hoffmann et al. | Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice | |
Gatto et al. | Analysis of YFP (J16)-R6/2 reporter mice and postmortem brains reveals early pathology and increased vulnerability of callosal axons in Huntington's disease | |
Porta et al. | Distinct brain‐derived TDP‐43 strains from FTLD‐TDP subtypes induce diverse morphological TDP‐43 aggregates and spreading patterns in vitro and in vivo | |
Saito et al. | Neocortical layer formation of human developing brains and lissencephalies: consideration of layer-specific marker expression | |
Pfeifenbring et al. | Remyelination after cuprizone-induced demyelination is accelerated in juvenile mice | |
De Rossi et al. | Aberrant accrual of BIN1 near Alzheimer’s disease amyloid deposits in transgenic models |